\-\ Texto\\:\\ \ \(0\)\
\-\ subtotal\\ surgical\\ resection\\.\ \(0\)\
\-\ radiation\\ therapy\\ was\\ withheld\\ at\\ this\\ point\\ secondary\\ to\\ the\\ low\\ grade\\ pathology\\.\ \(0\)\
\-\ homogeneous\\ mass\\ centered\\ in\\ the\\ right\\ petro\\-clival\\ fissure\\.\\ low\\ signal\\ on\\ t1\\,\\ high\\ on\\ t2\\,\\ with\\ marked\\ homogeneous\\ enhancement\\.\\ there\\ is\\ also\\ extension\\ of\\ the\\ tumor\\ through\\ the\\ skull\\ base\\ into\\ the\\ right\\ nasopharynx\\,\\ anterior\\ to\\ the\\ longus\\ colli\\ muscle\\ and\\ compressing\\ it\\.\\ the\\ lesion\\ is\\ also\\ producing\\ mass\\ effect\\ in\\ the\\ region\\ of\\ the\\ fossa\\ of\\ rosenmueller\\.\ \(0\)\
\-\ chondrosarcoma\\ of\\ the\\ skull\\ base\ \(0\)\
\-\ chondrosarcoma\ \(79\)\
\-\ chordoma\\ \\(same\\ mri\\ signal\\ pattern\\ but\\ usually\\ midline\\)\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ plasmacytoma\\ \\(usually\\ low\\ t2\\ on\\ mri\\)\ \(0\)\
\-\ lymphoma\\ \\(usually\\ lower\\ signal\\ on\\ t2\\ and\\ bright\\ dwi\\)\ \(0\)\
\-\ adenoid\\ cystic\\ carcinoma\\ \\(acc\\)\\ from\\ nasopharynx\ \(0\)\
\-\ 37\\ year\\ old\\ woman\\ who\\ presented\\ with\\ headaches\\.\ \(1\)\
\-\ in\\ this\\ case\\,\\ 37\\ year\\ old\\ woman\\ present\\ for\\ routine\\ mri\\ evaluation\\ for\\ symptoms\\ of\\ headache\\.\\ \\ abnormal\\ lesion\\ was\\ found\\ at\\ the\\ base\\ of\\ the\\ skull\\ which\\ was\\ then\\ worked\\ up\\ with\\ a\\ dedicated\\ mri\\ for\\ skull\\ base\\.\ \(0\)\
\-\ headaches\\ are\\ one\\ of\\ the\\ more\\ common\\ clinical\\ presentations\\ for\\ chondrosarcoma\\.\ \(0\)\
\-\ other\\ symptoms\\ include\\ cranial\\ nerve\\ palsies\\,\\ espcially\\ cn6\\ because\\ of\\ its\\ proximity\\ to\\ the\\ most\\ common\\ location\\ of\\ the\\ tumor\\.\\ \\ other\\ cn\\ that\\ could\\ be\\ involved\\ are\\ 3\\,\\ 5\\,\\ 6\\,\\ and\\ 8\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ skull\\:\\ 0\\.06384857353320472\ \(0\)\
\-\ base\\:\\ 0\\.05872733829528713\ \(0\)\
\-\ chondrosarcoma\\:\\ 0\\.05621346896969071\ \(0\)\
\-\ nasopharynx\\:\\ 0\\.05150069688421103\ \(0\)\
\-\ petro\\-clival\\:\\ 0\\.03866455449108113\ \(0\)\
\-\ espcially\\:\\ 0\\.03866455449108113\ \(0\)\
\-\ cn6\\:\\ 0\\.03866455449108113\ \(0\)\
\-\ 37\\:\\ 0\\.037664296902784715\ \(0\)\
\-\ acc\\:\\ 0\\.035624435278098915\ \(0\)\
\-\ homogeneous\\:\\ 0\\.03548099824123538\ \(0\)\
\-\ mri\\:\\ 0\\.03444343605113368\ \(0\)\
\-\ usually\\:\\ 0\\.0341437928140363\ \(0\)\
\-\ rosenmueller\\:\\ 0\\.033846079540782406\ \(0\)\
\-\ t2\\:\\ 0\\.031823536430925684\ \(0\)\
\-\ low\\:\\ 0\\.03126536911666315\ \(0\)\
\-\ colli\\:\\ 0\\.030805960327800187\ \(0\)\
\-\ signal\\:\\ 0\\.029645714872010245\ \(0\)\
\-\ palsies\\:\\ 0\\.029544196852134483\ \(0\)\
\-\ headaches\\:\\ 0\\.028653002974309456\ \(0\)\
\-\ presentations\\:\\ 0\\.02776584111481797\ \(0\)\
\-\ subtotal\\:\\ 0\\.0274147766074779\ \(0\)\
\-\ withheld\\:\\ 0\\.027089741641891398\ \(0\)\
\-\ dedicated\\:\\ 0\\.026787141328352138\ \(0\)\
\-\ adenoid\\:\\ 0\\.026504077639152263\ \(0\)\
\-\ worked\\:\\ 0\\.025750348442105515\ \(0\)\
\-\ plasmacytoma\\:\\ 0\\.025525377852686434\ \(0\)\
\-\ proximity\\:\\ 0\\.025525377852686434\ \(0\)\
\-\ longus\\:\\ 0\\.02531138590457489\ \(0\)\
\-\ chordoma\\:\\ 0\\.0245466780662206\ \(0\)\
\-\ compressing\\:\\ 0\\.0227102292291233\ \(0\)\
\-\ centered\\:\\ 0\\.021968666378053413\ \(0\)\
\-\ producing\\:\\ 0\\.021506558853238385\ \(0\)\
\-\ cn\\:\\ 0\\.020157941749080664\ \(0\)\
\-\ fissure\\:\\ 0\\.020093911927058065\ \(0\)\
\-\ dwi\\:\\ 0\\.01990724695153703\ \(0\)\
\-\ common\\:\\ 0\\.019616379052249097\ \(0\)\
\-\ bright\\:\\ 0\\.018737822989896905\ \(0\)\
\-\ symptoms\\:\\ 0\\.018681205937702974\ \(0\)\
\-\ tumor\\:\\ 0\\.017475721943954484\ \(0\)\
\-\ woman\\:\\ 0\\.017314938135867597\ \(0\)\
\-\ other\\:\\ 0\\.017277531128968845\ \(0\)\
\-\ point\\:\\ 0\\.016377693241149276\ \(0\)\
\-\ cranial\\:\\ 0\\.016296719281325873\ \(0\)\
\-\ involved\\:\\ 0\\.01572109564522768\ \(0\)\
\-\ same\\:\\ 0\\.015448305259833359\ \(0\)\
\-\ pathology\\:\\ 0\\.015339466798781938\ \(0\)\
\-\ fossa\\:\\ 0\\.015275436976759336\ \(0\)\
\-\ lesion\\:\\ 0\\.015268028298249602\ \(0\)\
\-\ routine\\:\\ 0\\.015028274974342093\ \(0\)\
\-\ also\\:\\ 0\\.014777364856755713\ \(0\)\
\-\ marked\\:\\ 0\\.014626664476423273\ \(0\)\
\-\ midline\\:\\ 0\\.014500570558502283\ \(0\)\
\-\ pattern\\:\\ 0\\.014326501487154728\ \(0\)\
\-\ grade\\:\\ 0\\.014275599969083203\ \(0\)\
\-\ its\\:\\ 0\\.014142681769542286\ \(0\)\
\-\ 8\\:\\ 0\\.014013673501093633\ \(0\)\
\-\ could\\:\\ 0\\.013827008525572596\ \(0\)\
\-\ nerve\\:\\ 0\\.013504149677575903\ \(0\)\
\-\ muscle\\:\\ 0\\.013461908918536599\ \(0\)\
\-\ extension\\:\\ 0\\.013378628601673917\ \(0\)\
\-\ then\\:\\ 0\\.01333757402816706\ \(0\)\
\-\ effect\\:\\ 0\\.013269992338023003\ \(0\)\
\-\ because\\:\\ 0\\.013111922441166875\ \(0\)\
\-\ location\\:\\ 0\\.013073279328525846\ \(0\)\
\-\ was\\:\\ 0\\.013003651608074826\ \(0\)\
\-\ headache\\:\\ 0\\.012872743147218412\ \(0\)\
\-\ for\\:\\ 0\\.012791371028819562\ \(0\)\
\-\ on\\:\\ 0\\.012699842322200491\ \(0\)\
\-\ \\(\\:\\ 0\\.012673012741120359\ \(0\)\
\-\ \\)\\:\\ 0\\.012518205124794825\ \(0\)\
\-\ radiation\\:\\ 0\\.01229934758579972\ \(0\)\
\-\ t1\\:\\ 0\\.011879366386948437\ \(0\)\
\-\ found\\:\\ 0\\.011811515852860142\ \(0\)\
\-\ resection\\:\\ 0\\.011688226559299204\ \(0\)\
\-\ clinical\\:\\ 0\\.01153206052660528\ \(0\)\
\-\ 6\\:\\ 0\\.011193509479714361\ \(0\)\
\-\ 5\\:\\ 0\\.010965615887912996\ \(0\)\
\-\ evaluation\\:\\ 0\\.010887012262398278\ \(0\)\
\-\ cystic\\:\\ 0\\.010809792575665606\ \(0\)\
\-\ lymphoma\\:\\ 0\\.01071139751925213\ \(0\)\
\-\ abnormal\\:\\ 0\\.010689001054012768\ \(0\)\
\-\ through\\:\\ 0\\.010644548326407318\ \(0\)\
\-\ carcinoma\\:\\ 0\\.010622489780771344\ \(0\)\
\-\ region\\:\\ 0\\.010585970294909266\ \(0\)\
\-\ include\\:\\ 0\\.010513831087852135\ \(0\)\
\-\ secondary\\:\\ 0\\.01047820160749477\ \(0\)\
\-\ mass\\:\\ 0\\.010425096552171617\ \(0\)\
\-\ high\\:\\ 0\\.010256780969635155\ \(0\)\
\-\ are\\:\\ 0\\.010218191864294752\ \(0\)\
\-\ presented\\:\\ 0\\.010216480855361443\ \(0\)\
\-\ one\\:\\ 0\\.010156716593467736\ \(0\)\
\-\ at\\:\\ 0\\.010155817130102043\ \(0\)\
\-\ up\\:\\ 0\\.010078276978307996\ \(0\)\
\-\ enhancement\\:\\ 0\\.010046003360188753\ \(0\)\
\-\ therapy\\:\\ 0\\.010020354369476372\ \(0\)\
\-\ who\\:\\ 0\\.00977179126816536\ \(0\)\
\-\ anterior\\:\\ 0\\.009652600104222532\ \(0\)\
\-\ \\,\\:\\ 0\\.009498598790080259\ \(0\)\
\-\ metastatic\\:\\ 0\\.009434690366737237\ \(0\)\
\-\ more\\:\\ 0\\.009373580304000729\ \(0\)\
\-\ the\\:\\ 0\\.009095347677870118\ \(0\)\
\-\ into\\:\\ 0\\.008918098105086434\ \(0\)\
\-\ 3\\:\\ 0\\.008776208450467279\ \(0\)\
\-\ most\\:\\ 0\\.008652785709333666\ \(0\)\
\-\ present\\:\\ 0\\.00846495067513895\ \(0\)\
\-\ this\\:\\ 0\\.008431028186966078\ \(0\)\
\-\ lower\\:\\ 0\\.008429219602473082\ \(0\)\
\-\ it\\:\\ 0\\.00842477361637288\ \(0\)\
\-\ year\\:\\ 0\\.008386888326955392\ \(0\)\
\-\ case\\:\\ 0\\.008199580845909082\ \(0\)\
\-\ but\\:\\ 0\\.00799343553084885\ \(0\)\
\-\ right\\:\\ 0\\.007909050079915936\ \(0\)\
\-\ surgical\\:\\ 0\\.007878165658997602\ \(0\)\
\-\ old\\:\\ 0\\.007674864884756619\ \(0\)\
\-\ which\\:\\ 0\\.0069962481896603005\ \(0\)\
\-\ that\\:\\ 0\\.0064735996866615055\ \(0\)\
\-\ disease\\:\\ 0\\.006126041847437299\ \(0\)\
\-\ be\\:\\ 0\\.005779634751508461\ \(0\)\
\-\ to\\:\\ 0\\.005619317216355082\ \(0\)\
\-\ there\\:\\ 0\\.0055776998090569675\ \(0\)\
\-\ from\\:\\ 0\\.005554542601553562\ \(0\)\
\-\ in\\:\\ 0\\.005544700396582301\ \(0\)\
\-\ is\\:\\ 0\\.004932375248988821\ \(0\)\
\-\ of\\:\\ 0\\.004598834242025859\ \(0\)\
\-\ and\\:\\ 0\\.0023685395491081372\ \(0\)\
\-\ \\.\\:\\ 0\\.0018683966367024354\ \(0\)\
\-\ a\\:\\ 0\\.001739472814993865\ \(0\)\
\-\ with\\:\\ 0\\.001539528632761707\ \(0\)\
